Expert: Stem cell rules will spur advances in genetic disorders

01/6/2010 | Yahoo!

The government's decision to overturn restrictions on federal funding for studies involving human embryonic stem cells is more likely to spur advances in the treatment of genetic diseases first "before we will see advances in cell-replacement therapy," said Story Landis, chairman of a stem cell task force at the NIH. Landis said the rules cover more stem cell lines, allowing scientists to study lines with disease-causing mutations and develop better treatments for genetic disorders.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN